SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001445305-14-003324
Filing Date
2014-08-01
Accepted
2014-08-01 15:29:56
Documents
10
Period of Report
2014-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q agen-6302014x10q.htm 10-Q 750607
2 CERTIFICATION OF PEO PURSUANT TO SECTION 302 agen-exhibit311q214.htm EX-31.1 13876
3 CERTIFICATION OF PFO PURSUANT TO SECTION 302 agen-exhibit312q214.htm EX-31.2 13371
4 CERTIFICATION OF PEO AND PFO PURSUANT TO SECTION 906 agen-exhibit321q214.htm EX-32.1 8999
  Complete submission text file 0001445305-14-003324.txt   4591703

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT agen-20140630.xml EX-101.INS 526201
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT agen-20140630.xsd EX-101.SCH 31112
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT agen-20140630_cal.xml EX-101.CAL 56318
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT agen-20140630_def.xml EX-101.DEF 160463
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT agen-20140630_lab.xml EX-101.LAB 510828
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT agen-20140630_pre.xml EX-101.PRE 276174
Mailing Address 162 FIFTH AVENUE SUITE 900 NEW YORK NY 10010
Business Address 162 FIFTH AVENUE SUITE 900 NEW YORK NY 10010 212-994-8200
AGENUS INC (Filer) CIK: 0001098972 (see all company filings)

IRS No.: 061562417 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-29089 | Film No.: 141009930
SIC: 2836 Biological Products, (No Diagnostic Substances)